Status:
COMPLETED
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
Lead Sponsor:
Southwestern Regional Medical Center
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
This study is being conducted in order to determine if intratumoral chemotherapy will be helpful in the palliation of endobronchial tumors when used in conjunction with endobronchial brachytherapy.
Detailed Description
Injections of cisplatin are given in conjunction with the brachytherapy procedure. If the direct intratumoral injections result in a decrease in the endobronchial obstructed airways and if the therapy...
Eligibility Criteria
Inclusion
- Patients with inoperable lung carcinoma and/or recurrent disease.
- Patients with symptomatic obstruction.
- Occlusion or partial occlusion of bronchi.
- Disease verified via bronchoscopy.
- Patients with a least one endobronchial tumor, measuring at least 0.5 cm.
- Patients between ages of 20 and 80 years.
- Documented informed consent must be obtained.
Exclusion
- Patients without diagnosis confirmed by bronchoscopy.
- Patients with endobronchial tumors measuring less than 0.5 cm.
- Patients younger than 20 or older than 80 years.
- Patients who do not sign informed consent form.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00379665
Start Date
October 1 2005
End Date
September 1 2012
Last Update
December 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Treatment Centers of America ® Southwestern Regional Medical Center
Tulsa, Oklahoma, United States, 74133